TrialGut2020

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis.

Yinglian Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.